Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma

od Engesæter, Birgit, Engebraaten, Olav, Flørenes, Vivi Ann, Mælandsmo, Gunhild Mari
Izdano 2012

Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening

od Hashim, Dana, Engesæter, Birgit, Baadstrand Skare, Gry, Castle, Philip E., Bjørge, Tone, Tropé, Ameli, Nygård, Mari
Izdano u Br J Cancer (2020)

hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma

od Fleten, Karianne G, Flørenes, Vivi Ann, Prasmickaite, Lina, Hill, Oliver, Sykora, Jaromir, Mælandsmo, Gunhild M, Engesæter, Birgit
Izdano u Cell Death Discov (2016)

Aldehyde Dehydrogenase (ALDH) Activity Does Not Select for Cells with Enhanced Aggressive Properties in Malignant Melanoma

od Prasmickaite, Lina, Engesæter, Birgit Ø., Skrbo, Nirma, Hellenes, Tina, Kristian, Alexandr, Oliver, Nina K., Suo, Zhenhe, Mælandsmo, Gunhild M.
Izdano 2010

Impact of scheduled appointments on cervical screening participation in Norway: a randomised intervention

od Lönnberg, Stefan, Andreassen, Trude, Engesæter, Birgit, Lilleng, Rune, Kleven, Cecilia, Skare, Annelie, Johansson, Karin, Fredheim, Christina Stangeland, Tropé, Ameli
Izdano u BMJ Open (2016)

Psychological effect of cervical cancer screening when changing primary screening method from cytology to high‐risk human papilloma virus testing

od Andreassen, Trude, Hansen, Bo T., Engesæter, Birgit, Hashim, Dana, Støer, Nathalie C., Tropé, Ameli, Moen, Kåre, Ursin, Giske, Weiderpass, Elisabete
Izdano u Int J Cancer (2019)

Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma

od Magnussen, Gry Irene, Emilsen, Elisabeth, Giller Fleten, Karianne, Engesæter, Birgit, Nähse-Kumpf, Viola, Fjær, Roar, Slipicevic, Ana, Flørenes, Vivi Ann
Izdano u BMC Cancer (2015)

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors

od Seip, Kotryna, Fleten, Karianne G., Barkovskaya, Anna, Nygaard, Vigdis, Haugen, Mads H., Engesæter, Birgit Ø., Mælandsmo, Gunhild M., Prasmickaite, Lina
Izdano u Oncotarget (2016)

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

od Slipicevic, Ana, Øy, Geir Frode, Rosnes, Anne Katrine Ree, Stakkestad, Øystein, Emilsen, Elisabeth, Engesæter, Birgit, Mælandsmo, Gunhild M., Flørenes, Vivi Ann
Izdano 2013

Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study

od Engesæter, Birgit, van Diermen Hidle, Bianca, Hansen, Mona, Moltu, Pia, Staby, Kjersti Mangseth, Borchgrevink-Persen, Siri, Vintermyr, Olav K., Lönnberg, Stefan, Nygård, Mari, Janssen, Emiel A. M., Castle, Philip E., Christiansen, Irene Kraus
Izdano u BMC Infect Dis (2016)